|
1
|
Torre LA, Islami F, Siegel RL, Ward EM and
Jemal A: Global cancer in women: Burden and trends. Cancer
Epidemiol Biomarkers Prev. 26:444–457. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Arps DP, Healy P, Zhao L, Kleer CG and
Pang JC: Invasive ductal carcinoma with lobular features: A
comparison study to invasive ductal and invasive lobular carcinomas
of the breast. Breast Cancer Res Treat. 138:719–726.
2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Siegel RL, Fedewa SA, Miller KD,
Goding-Sauer A, Pinheiro PS, Martinez-Tyson D and Jemal A: Cancer
statistics for Hispanics/Latinos, 2015. CA Cancer J Clin.
65:457–480. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
McCart Reed AE, Kutasovic JR, Lakhani SR
and Simpson PT: Invasive lobular carcinoma of the breast:
Morphology, biomarkers and 'omics. Breast Cancer Res.
17(12)2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ferlicot S, Vincent-Salomon A, Médioni J,
Genin P, Rosty C, Sigal-Zafrani B, Fréneaux P, Jouve M, Thiery JP
and Sastre-Garau X: Wide metastatic spreading in infiltrating
lobular carcinoma of the breast. Eur J Cancer. 40:336–341.
2004.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Arpino G, Bardou VJ, Clark GM and Elledge
RM: Infiltrating lobular carcinoma of the breast: Tumor
characteristics and clinical outcome. Breast Cancer Res.
6:R149–R156. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
He H, Gonzalez A, Robinson E and Yang WT:
Distant metastatic disease manifestations in infiltrating lobular
carcinoma of the breast. AJR Am J Roentgenol. 202:1140–1148.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
McLemore EC, Pockaj BA, Reynolds C, Gray
RJ, Hernandez JL, Grant CS and Donohue JH: Breast cancer:
Presentation and intervention in women with gastrointestinal
metastasis and carcinomatosis. Ann Surg Oncol. 12:886–894.
2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Oda Kondo H, Yamao T, Saito D, Ono H,
Gotoda T, Yamaguchi H, Yoshida S and Shimoda T: Metastatic tumors
to the stomach: Analysis of 54 patients diagnosed at endoscopy and
347 autopsy cases. Endoscopy. 33:507–510. 2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Taal BG, Peterse H and Boot H: Clinical
presentation, endoscopic features, and treatment of gastric
metastases from breast carcinoma. Cancer. 89:2214–2221.
2000.PubMed/NCBI
|
|
11
|
Greene FL: Breast tumours. In: TNM
classification of malignant tumours. Sobin LH, Gospodarowicz MK and
Wittekind C (eds). 7th edition. Wiley-Blackwell, Oxford, pp181-193,
2009.
|
|
12
|
Korhonen T, Kuukasjärvi T, Huhtala H,
Alarmo EL, Holli K, Kallioniemi A and Pylkkänen L: The impact of
lobular and ductal breast cancer histology on the metastatic
behavior and long term survival of breast cancer patients. Breast.
22:1119–1124. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Christgen M and Derksen P: Lobular breast
cancer: Molecular basis, mouse and cellular models. Breast Cancer
Res. 17(16)2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
de Groot JS, Ratze MA, van Amersfoort M,
Eisemann T, Vlug EJ, Niklaas MT, Chin SF, Caldas C, van Diest PJ,
Jonkers J, et al: αE-catenin is a candidate tumor suppressor for
the development of E-cadherin-expressing lobular-type breast
cancer. J Pathol. 245:456–467. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Rakha EA, Patel A, Powe DG, Benhasouna A,
Green AR, Lambros MB, Reis-Filho JS and Ellis IO: Clinical and
biological significance of E-cadherin protein expression in
invasive lobular carcinoma of the breast. Am J Surg Pathol.
34:1472–1479. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Berx G, Cleton-Jansen AM, Nollet F, de
Leeuw WJ, van de Vijver M, Cornelisse C and van Roy F: E-cadherin
is a tumour/invasion suppressor gene mutated in human lobular
breast cancers. EMBO J. 14:6107–6115. 1995.PubMed/NCBI
|
|
17
|
Schwarz RE, Klimstra DS and Turnbull AD:
Metastatic breast cancer masquerading as gastrointestinal primary.
Am J Gastroenterol. 93:111–114. 1998.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ushida Y, Yoshimizu S, Horiuchi Y, Yoshio
T, Ishiyama A, Hirasawa T, Tsuchida T and Fujisaki J:
Clinicopathological features of metastatic gastric tumors
originating from breast cancer: Analysis of eleven cases. World J
Oncol. 9:104–109. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Pectasides D, Psyrri A, Pliarchopoulou K,
Floros T, Papaxoinis G, Skondra M, Papatsibas G, Macheras A,
Athanasas G, Arapantoni-Datioti P and Economopoulos T: Gastric
metastases originating from breast cancer: Report of 8 cases and
review of the literature. Anticancer Res. 29:4759–4763.
2009.PubMed/NCBI
|
|
20
|
Kim GH, Ahn JY, Jung HY, Park YS, Kim MJ,
Choi KD, Lee JH, Choi KS, Kim DH, Lim H, et al: Clinical and
endoscopic features of metastatic tumors in the stomach. Gut Liver.
9:615–622. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
D'Angelo F, Rampini A, Cardella S,
Antolino L, Nigri G, Valabrega S, Aurello P and Ramacciato P:
Breast cancer metastasis to the stomach. J Cancer Metastasis Treat.
5(30)2019.
|
|
22
|
Insko EK, Levine MS, Birnbaum BA and
Jacobs JE: Benign and malignant lesions of the stomach: Evaluation
of CT criteria for differentiation. Radiology. 228:166–171.
2003.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Shimada H, Okazumi S, Koyama M and
Murakami K: Japanese gastric cancer association task force for
research promotion: Clinical utility of 18F-fluoro-2-deoxyglucose
positron emission tomography in gastric cancer. A systematic review
of the literature. Gastric Cancer. 14:13–21. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yun M: Imaging of gastric cancer
metabolism using 18 F-FDG PET/CT. J Gastric Cancer. 14:1–6.
2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Pera M, Riera E, Lopez R, Vinolas N,
Romagosa C and Miquel R: Metastatic carcinoma of the breast
resembling early gastric carcinoma. Mayo Clin Proc. 76:205–207.
2001.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Eo WK: Breast cancer metastasis to the
stomach resembling early gastric cancer. Cancer Res Treat.
40:207–210. 2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
O'Connell FP, Wang HH and Odze RD: Utility
of immunohistochemistry in distinguishing primary adenocarcinomas
from metastatic breast carcinomas in the gastrointestinal tract.
Arch Pathol Lab Med. 129:338–347. 2005.PubMed/NCBI View Article : Google Scholar
|
|
28
|
van Velthuysen ML, Taal BG, van der Hoeven
JJ and Peterse JL: Expression of oestrogen receptor and loss of
E-cadherin are diagnostic for gastric metastasis of breast
carcinoma. Histopathology. 46:153–157. 2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Koike K, Kitahara K, Higaki M, Urata M,
Yamazaki F and Noshiro H: Clinicopathological features of gastric
metastasis from breast cancer in three cases. Breast Cancer.
21:629–634. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Viacava P, Naccarato AG and Bevilacqua G:
Spectrum of GCDFP-15 expression in human fetal and adult normal
tissues. Virchows Arch. 432:255–260. 1998.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Mazoujian G, Bodian C, Haagensen DE Jr and
Haagensen CD: Expression of GCDFP-15 in breast carcinomas.
Relationship to pathologic and clinical factors. Cancer.
63:2156–2161. 1989.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Gown AM, Fulton RS and Kandalaft PL:
Markers of metastatic carcinoma of breast origin. Histopathology.
68:86–95. 2016.PubMed/NCBI View Article : Google Scholar
|
